Gelatin-Based Electrospun
Nanofibers Varied in Morphologies
with Poly(ethylene imine) and Poly(2-ethyl-2-oxazoline): Allantoin-Modified
for Antimicrobial Skin Compatibility
This study focuses on developing and thoroughly assessing
innovative,
nontoxic, antibacterial, and skin-compatible electrospun nanofibrous
mats-coated cotton composites. Materials were created by selectively
incorporating different polyethylenimine polymers (PEI) and poly(2-ethyl-2-oxazoline)-based
(P2Ox) polymers into a gelatin biopolymer matrix, which was then electrospun
onto a cotton fabric substrate. Three distinct variants of PEI, such
as branched PEI (BPEI), linear PEI (LPEI), and a P2Ox-based copolymer
(P2Ox-co-PEI), were systematically integrated to fabricate hybrid,
Janus, and core–shell electrospun structures, facilitating
prominent change of their effects on the resultant material properties.
Morphological investigation indicated that electrospun fibers in hybrid
morphology have a smaller average diameter (200 nm) than core–shell
counterparts (360 nm), although all produced mats demonstrated intrinsic
hydrophilicity. The air permeability of the samples exhibited considerable
variation between 41 and 1130 L/m2/s airflow rates. To
enhance the biocompatibility and bioactivity of the nanofibrous mat
surfaces, the materials were subjected to postprocessing by the chemical
bonding of Allantoin (Alla). The antimicrobial effectiveness was also
confirmed against Staphylococcus aureus (bacteria) and Candida albicans (Fungi)
through the agar diffusion test, with the highest inhibitory impact
at 18 and 20 mm, respectively. Notably, all electrospun mats, especially
those modified with Alla, promoted L929 fibroblast proliferation,
demonstrating superior biocompatibility. Finally, the biocompatibility
of the Alla-modified samples was further investigated by a skin irritation
test against human epidermal keratinocytes. The developed composites
are biocompatible, nontoxic, and highly skin-compatible and have considerable
potential for biomedical applications, such as wound dressings, drug
delivery systems, and tissue engineering scaffolds.